Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer
- 9 August 2007
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 110 (1) , 153-159
Abstract
The negative association between the oestrogen receptor (ER) and the human epidermal growth factor receptor 2 (HER-2) in breast cancer travels in both directions. ER+ tumours are less likely HER-2+ and HER-2+ tumours are less likely ER+.Keywords
This publication has 25 references indexed in Scilit:
- Prognostic Implications of HER-2 Status in Steroid Receptor–Positive, Lymph Node–Negative Breast CarcinomaAmerican Journal of Clinical Pathology, 2007
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- IN REPLYJournal of Clinical Oncology, 2006
- Histopathologic Characteristics Predicting HER-2/neu Amplification in Breast CancerThe Breast Journal, 2005
- Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancerJournal of Clinical Pathology, 2005
- Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-relatedBreast Cancer Research and Treatment, 2005
- HER‐2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and youngerCancer, 2005
- Do we need HER‐2/neu testing for all patients with primary breast carcinoma?Cancer, 2003
- Enzyme-linked immunosorbent assay of HER-2/neu gene product (p185) in breast cancer: its correlation with sex steroid receptors, cathepsin D and histologic gradesCancer Letters, 1993
- Epidemiology of breast carcinoma IV: Age and histologic tumor typeJournal of Surgical Oncology, 1982